Study findings The risk of new-onset DR was slightly higher among GLP-1 RA users (hazard ratio 1.07, a 0.2% absolute increase over two years), but the incidence of NAION was numerically higher but not statistically significant in this group
Flying Blind: unveiling the patchy landscape of global R&D for endometriosis, polycystic ovary syndrome and uterine fibroids By Impact Global Health 10 September 2025 Common yet ignored: the neglect of gynaecological conditions in medical research Endometriosis, polycystic ovary syndrome (PCOS) and uterine fibroids are common gynaecological conditions that affect the health and wellbeing of millions of women 1 worldwide
Today we will dive deep into some frequently asked questions so that you are well informed and confident in your decision to include glutathione supplements in your diet
The timing varies between individuals based on genetic factors, starting dose, and how rapidly your provider increases your dose
A 2021 systematic review noted inconsistent bioavailability data and called for more rigorous clinical trials
For instance, a study indicated that treatment with GLP-1 receptor agonists during the proestrus phase in animal models doubled serum luteinizing hormone (LH) levels and increased the number of mature Graafian follicles, which are essential for ovulation and fertility
